| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/19/2023 | 17.21% | JP Morgan | $89 → $79 | Maintains | Neutral |
| 10/12/2023 | 24.63% | Oppenheimer | $96 → $84 | Maintains | Outperform |
| 08/07/2023 | 36.5% | Roth MKM | → $92 | Upgrades | Neutral → Buy |
| 06/27/2023 | 42.43% | Oppenheimer | → $96 | Reiterates | Outperform → Outperform |
| 06/16/2023 | 30.56% | Citigroup | → $88 | Reiterates | Neutral → Neutral |
| 05/22/2023 | 32.05% | Barclays | → $89 | Initiates Coverage On | → Equal-Weight |
| 05/11/2023 | 42.43% | Oppenheimer | → $96 | Reiterates | Outperform → Outperform |
| 05/11/2023 | 36.5% | Roth MKM | $93 → $92 | Maintains | Neutral |
| 03/27/2023 | 30.56% | Citigroup | $91 → $88 | Maintains | Neutral |
| 03/01/2023 | 55.79% | UBS | → $105 | Upgrades | Neutral → Buy |
| 02/27/2023 | 37.98% | Roth MKM | $104 → $93 | Maintains | Neutral |
| 02/24/2023 | 42.43% | Oppenheimer | $106 → $96 | Maintains | Outperform |
| 10/21/2022 | 35.01% | Citigroup | → $91 | Initiates Coverage On | → Neutral |
| 10/20/2022 | 30.56% | JP Morgan | $97 → $88 | Maintains | Neutral |
| 08/08/2022 | 43.92% | JP Morgan | $90 → $97 | Maintains | Neutral |
| 08/08/2022 | 43.92% | Oppenheimer | $85 → $97 | Maintains | Outperform |
| 07/20/2022 | 18.69% | JP Morgan | $77 → $80 | Maintains | Neutral |
| 02/25/2022 | 26.11% | Oppenheimer | $86 → $85 | Maintains | Outperform |
| 01/26/2022 | 11.28% | B of A Securities | $94 → $75 | Downgrades | Buy → Neutral |
| 07/21/2021 | 32.05% | JP Morgan | $83 → $89 | Maintains | Overweight |
| 07/16/2021 | 12.76% | Roth Capital | $97 → $76 | Maintains | Neutral |
| 07/15/2021 | 12.76% | Roth Capital | $97 → $76 | Maintains | Neutral |
| 02/02/2021 | 48.37% | Roth Capital | $70 → $100 | Maintains | Neutral |
| 01/06/2021 | 27.6% | JP Morgan | → $86 | Downgrades | Overweight → Neutral |
| 07/09/2020 | 21.66% | JP Morgan | → $82 | Upgrades | Neutral → Overweight |
| 10/24/2019 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 08/23/2019 | 8.31% | UBS | $59 → $73 | Maintains | Neutral |
| 03/06/2019 | — | JP Morgan | Downgrades | Overweight → Neutral |
What is the target price for Ormat Technologies (ORA)?
There is no price target for Ormat Technologies
What is the most recent analyst rating for Ormat Technologies (ORA)?
There is no analyst for Ormat Technologies
When is the next analyst rating going to be posted or updated for Ormat Technologies (ORA)?
There is no next analyst rating for Ormat Technologies
Is the Analyst Rating Ormat Technologies (ORA) correct?
There is no next analyst rating for Ormat Technologies
